Fair Value Measurement - Schedule of Fair Value of the Company’s Level 3 Financial Instruments (Details) - Level 3 [Member] - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Schedule of Fair Value of the Company’s Level 3 Financial Instruments [Line Items] | ||||
| Fair value as of beginning balance | $ 2,234 | $ 1,714 | $ 1,714 | |
| Issuance of Convertible Notes | 16 | 16 | $ 1,600 | |
| Accrued stated interest | 95 | 48 | 194 | 92 |
| Change in fair value included in other income and gain on change in the fair value of Tasly convertible debt | 61 | (4) | 311 | 22 |
| Fair value as of Ending balance | $ 2,390 | $ 1,774 | $ 2,234 | $ 1,714 |
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. No definition available.
|
| X | ||||||||||
- Definition The amount of accrued stated interest. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|